Gut impairment could trigger inflammation in several ways, among others by LPS‐priming of the NLRP3 inflammasome, which has been shown to play a central role in CVD [33, 34, 35] as well as in the pathogenesis of COVID‐19 [36]. Here, NLRP3 is linked to COVID-19.